Dec 5, 2015 Syros Pharmaceuticals Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of First-in-Class Selective CDK7 Inhibitor in Models of Acute Leukemias
Nov 10, 2015 Syros Pharmaceuticals Announces Issuance of U.S. Patents Related to Its Gene Control Drug Discovery and Development Platform
Nov 5, 2015 Syros Pharmaceuticals to Present Preclinical Data on First-in-Class Selective CDK7 Inhibitor Program at American Society of Hematology (ASH) Annual Meeting
Oct 19, 2015 Syros Pharmaceuticals Appoints Industry Leader Marsha H. Fanucci to Its Board of Directors
Sep 30, 2015 FierceBiotech Names Syros Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2015
Sep 24, 2015 Syros Pharmaceuticals Announces New Publication Highlighting the Strong Potential of CDK7 Inhibition in Difficult-to-Treat Cancer
Sep 24, 2015 Syros Pharmaceuticals Licenses Clinical-Stage RARα Agonist to Develop and Commercialize for Genomically-Defined Cancer Populations Identified by Gene Control Platform
